Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Clinical trial NCT04844489 · COMPLETED

Trial details

NCT number: NCT04844489
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Autoimmune or Autoinflammatory Diseases HIV Multiple Sclerosis Solid Tumors or Cancers Solid Organ Transplant

Start date: 2021-04-16
Primary completion: 2022-11-24
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.